Healthcare AI startup Delphyr has raised €1.75m to expand its platform for medical professionals, with backing from the founders of Hugging Face and DEGIRO.
The Amsterdam-based company will use the funding to support product development and deployment across hospitals, primary care and mental health settings, according to Beinsure.
Founded in 2023, the Dutch firm develops AI agents designed to support clinicians by reducing the time spent on documentation and information retrieval.
The platform aggregates patient data from clinical notes, laboratory results and correspondence into a single interface, allowing physicians to search records and access clinical information more quickly.
Michel Abdel Malek, CEO and Founder of Delphyr, said, “Clinicians lose hours to documentation and information retrieval, which drags on productivity and morale.”
Delphyr said the new funding will support further development of AI agents aimed at returning time to practitioners while maintaining privacy, security and clinical standards.
The platform also enables physicians to retrieve clinical guidelines and vetted medical sources within seconds, providing a consolidated view of patient records.
Additional features include generating patient summaries, drafting consultation notes and preparing responses for correspondence and electronic consultations.
Ambient listening technology can capture consultations, convert speech into structured clinical notes and link outputs directly to the patient record.
Delphyr integrates with existing healthcare IT systems so medical professionals can access the platform without switching software or managing additional dashboards.
The company positions the product as an intelligence layer that works alongside existing healthcare systems rather than replacing them.
Delphyr said its platform is designed to comply with evolving European regulation, including the EU Artificial Intelligence Act, and processes patient data entirely within European infrastructure.
The company added that its model is purpose-built for medical use and includes end-to-end monitoring to support compliance and governance requirements.
In 2024, Delphyr secured a €275,000 convertible loan from Innovatiefonds Noord-Holland, providing early financial support ahead of the latest funding round.
The investment reflects a broader trend of funding flowing into AI-driven workflow automation in European healthcare systems facing operational and cost pressures.
Investors are increasingly supporting technologies designed to automate administrative tasks and improve clinical productivity while maintaining strong data governance standards.
Keep up with all the latest FinTech news here
Copyright © 2026 FinTech Global
Investors
The following investor(s) were tagged in this article.
